Coverage of our peer-reviewed research in the healthcare and mainstream press.
A PatientEngagementHIT.com article summarized the findings of a study that appeared in the June issue of The American Journal of Managed Care® (AJMC®). In “Patients’ Views on Price Shopping and Price Transparency,” researchers interviewed individuals who had access to a price transparency tool and found that while they had positive opinions of price shopping, they rarely used the tool. “Ultimately, patients need better guidance from the healthcare industry while using price transparency tools,” the PatientEngagementHIT.com article concluded.
®. The article "How Do Medicare Advantage Beneficiary Payments Vary With Tenure?" found that beneficiaries paid more in excess of the lowest-cost plan the longer they were enrolled in their plans. "
While some enrollees may intentionally choose higher-cost plans, the option to passively re-enroll in the same plan year after year may help explain these findings," the AHRQ newsletter summarized.
The Agency for Healthcare Research and Quality (AHRQ) News Now e-newsletter on Wednesday highlighted another study from the June issue of AJMC
An article on PatientEngagementHIT.com cited AJMC® research to discuss how technology tools like patient portals can help boost engagement. The referenced study, “Patients’ Preferences for Receiving Laboratory Test Results,” was published in the April issue of AJMC® and found that 98% of participants preferred to receive a text message when their laboratory test results were ready.
Global Trends in Ovarian Cancer Incidence Highlight Regional, Histological Variations
January 7th 2025Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, influenced by genetic, reproductive, and socioeconomic factors.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Decisions and Precision in Value-Based Cancer Care
January 7th 2025An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for multiple myeloma, and more.
Read More